Recent work by the Rosenberg group revealed KRASmut-specific CD4+ T-cells [52], and KRAS-specific tumor-infiltrating IgG B-cells were identified in patients with pancreatic cancer [53]. The gene discussed is CD4; the disease is neoplasm.